FLT3 and acute myeloid leukemia: In AML-393 primary cells, targeting of FLT3 or FcγRI alone with 20D9h3-LALA-DUBA or IgG1-DUBA, reduced CFC to 53.2% ± 2.0% and 65.5% ± 11.2%, respectively.